Treatment of elderly and unfit patients with CRC
Treatment of elderly and unfit patients with CRC
Prof. Hans Prenen, Asst. Prof. Joleen Hubbard
Ass. Prof. Fotios Loupakis, Prof. Hans Prenen and Ass. Prof. Joleen Hubbard discuss the Clinical Question: How to treat (or not) elderly colorectal cancer patients? Unfit: a relative conceptProf. Hans Prenen
Medical Oncologist
University Hospital Antwerp
Belgium
Hans Prenen obtained his medical degree and PhD at the Catholic University Leuven. He is currently the head of the Medical Oncology Department at the University Hospital Antwerp and director of the Oncology Clinical Trial Unit. He is member of several scientific organisations including the Belgian Society of Medical Oncology (board member since 2015) and the European Society of Medical oncology (scientific committee). He is a recognised international expert in the field of cancer and is regularly invited to national and international meetings and has published more than 160 peer reviewed scientific papers.
He is principal investigator of several clinical trials with a focus on phase 1 and basket trials.
His research interests relate to translational studies on targeted therapies, new anticancer therapies and understanding the molecular changes induced by anticancer therapy.
Prof. Hans Prenen has no relevant financial relationships to disclose.
Asst. Prof. Joleen Hubbard
Medical Oncologist
Mayo Cinic Rochester
United States (US)
Dr. Joleen Hubbard is an Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota, U.S., and hematology/oncology training at Mayo Clinic, Rochester, Minnesota, U.S. Dr. Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr. Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network. Dr. Hubbard is the chair of the Gastrointestinal Tumor Group Practice at Mayo Clinic Rochester, Minnesota, U.S.
|
5 min
|
2016
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.